Embattled biotech appoints new president, 7 months after former CEO ousted


The new leader will have his work cut out for him in leading the embattled company.

Previous CapStar CEO: 'Never say never' but new markets aren't the bank's focus
Next Peninsula biotech sheds half its value after deciding to continue multiple sclerosis study